Alencherry Ben, Erem Geoffrey, Mirembe Grace, Ssinabulya Isaac, Yun Chun-Ho, Hung Chung-Lieh, Siedner Mark J, Bittencourt Marcio, Kityo Cissy, McComsey Grace A, Longenecker Chris T
Medicine and Pediatrics, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Radiology, St Francis Hospital Nsambya, Kampala, Uganda.
Open Heart. 2019 May 22;6(1):e001046. doi: 10.1136/openhrt-2019-001046. eCollection 2019.
To compare the prevalence of detectable coronary artery calcium (CAC) among higher risk, older people living with HIV (PLWH) and uninfected persons in Uganda versus the USA, and second to explore associations of CAC with HIV-specific variables and biomarkers of inflammation.
This cross-sectional study of 430 total subjects compared 100 PLWH on antiretroviral therapy and 100 age-matched and sex-matched HIV-uninfected controls in Uganda with 167 PLWH on antiretroviral therapy and 63 uninfected controls in the USA. Multivariable logistic regression was used to examine associations with detectable CAC (CAC >0).
Compared with US subjects, Ugandans were older (mean age 56 vs 52 years) and were more likely to have diabetes (36% vs 3%) and hypertension (85% vs 36%), but were less likely to be male (38% vs 74%) or smokers (4% vs 56%). After adjustment for HIV serostatus, age, sex and traditional risk factors, Ugandans had substantially lower odds of CAC >0 (adjusted OR 0.07 (95% CI 0.03 to 0.17), p<0.001). HIV was not associated with CAC >0 in either country (p>0.1). Among all PLWH, nadir CD4 count was associated with the presence of CAC, and among Ugandans soluble intercellular adhesion molecule (p=0.044), soluble CD163 (p=0.004) and oxidised low-density lipoprotein (p=0.043) were all associated with the presence of CAC.
Ugandans had a dramatically lower prevalence of any coronary calcification compared with US subjects. The role of HIV infection and inflammation as risk factors for subclinical coronary disease in sub-Saharan Africa merits further investigation.
比较乌干达和美国高危老年艾滋病毒感染者(PLWH)与未感染者中可检测到的冠状动脉钙化(CAC)的患病率,其次探讨CAC与艾滋病毒特异性变量及炎症生物标志物之间的关联。
这项横断面研究共纳入430名受试者,比较了乌干达100名接受抗逆转录病毒治疗的PLWH及100名年龄和性别匹配的未感染艾滋病毒的对照者,以及美国167名接受抗逆转录病毒治疗的PLWH和63名未感染对照者。采用多变量逻辑回归分析来检验与可检测到的CAC(CAC>0)的关联。
与美国受试者相比,乌干达人年龄更大(平均年龄56岁对52岁),患糖尿病(36%对3%)和高血压(85%对36%)的可能性更高,但男性比例(38%对74%)和吸烟者比例(4%对56%)更低。在调整了艾滋病毒血清学状态、年龄、性别和传统风险因素后,乌干达人CAC>0的几率显著更低(调整后的OR为0.07(95%CI 0.03至0.17),p<0.001)。在两个国家,艾滋病毒均与CAC>0无关(p>0.1)。在所有PLWH中,最低CD4细胞计数与CAC的存在有关,在乌干达人中,可溶性细胞间粘附分子(p=0.044)、可溶性CD163(p=0.004)和氧化型低密度脂蛋白(p=0.043)均与CAC的存在有关。
与美国受试者相比,乌干达人任何冠状动脉钙化的患病率显著更低。在撒哈拉以南非洲,艾滋病毒感染和炎症作为亚临床冠状动脉疾病风险因素的作用值得进一步研究。